FGFR1 and PROKR2 rare variants found in patients with combined pituitary hormone deficiencies

Endocrine Connections

Volumn 4, Issue 2, 2015, Pages 100-107

  Correa, Fernanda A ^a   Trarbach, Ericka B ^a   Tusset, Cintia ^a   Latronico, Ana Claudia ^a   Montenegro, Luciana R ^a   Carvalho, Luciani R ^a   Franca, Marcela M ^a   Otto, Aline P ^a   Costalonga, Everlayny F ^a   Brito, Vinicius N ^a   Abreu, Ana Paula ^c   Nishi, Mirian Y ^a   Jorge, Alexander A L ^a   Arnhold, Ivo J P ^a   Sidis, Yisrael ^b   Pitteloud, Nelly ^b   Mendonca, Berenice B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Combined pituitary hormone deficiencies; FGFR1; Hypopituitarism; PROKR2

Indexed keywords

BETA ACTIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HYPOPHYSIS HORMONE;

ADOLESCENT; ADULT; ARTICLE; BRAZILIAN; CELL SURFACE; CHILD; FEMALE; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GLI2 GENE; HESX1 GENE; HUMAN; HYPOPITUITARISM; IMMUNOREACTIVITY; LHX4 GENE; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; OTX2 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROKR2 GENE; PROTEIN EXPRESSION; SCHOOL CHILD; SOX3 GENE; WESTERN BLOTTING; YOUNG ADULT;

EID: 85003546656     PISSN: None     EISSN: 20493614     Source Type: Journal    
DOI: 10.1530/EC-15-0015     Document Type: Article

References (27)

1. Davis SW, Castinetti F, Carvalho LR, Ellsworth BS, Potok MA, Lyons RH, Brinkmeier ML, Raetzman LT, Carninci P, Mortensen AH et al. Molecular mechanisms of pituitary organogenesis: in search of novel regulatory genes. Molecular and Cellular Endocrinology 2010 323 4-19. (doi:10.1016/j.mce.2009.12.012)
2. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC & Dattani MT. Genetic regulation of pituitary gland development in human and mouse. Endocrine Reviews 2009 30 790-829. (doi:10.1210/er.2009-0008)
3. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J, Sykiotis GP, Gregory LC, Diaczok D, Tziaferi V et al. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. Journal of Clinical Endocrinology and Metabolism 2012 97 E694-E699. (doi:10.1210/jc.2011-2938)
4. Streit A. The preplacodal region: an ectodermal domain with multipotential progenitors that contribute to sense organs and cranial sensory ganglia. International Journal of Developmental Biology 2007 51 447-461. (doi:10.1387/ijdb.072327as)
5. McCabeMJ, Gaston-Massuet C, Tziaferi V, Gregory LC, Alatzoglou KS, SignoreM, Puelles E, Gerrelli D, Farooqi IS, Raza J et al. Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction. Journal of Clinical Endocrinology andMetabolism 2011 96 E1709-E1718. (doi:10.1210/jc.2011-0454)
6. Matsumoto S, Yamazaki C, Masumoto KH, Nagano M, Naito M, Soga T, Hiyama H, Matsumoto M, Takasaki J, Kamohara M et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. PNAS 2006 103 4140-4145. (doi:10.1073/pnas.0508881103)
7. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H & Zhou QY. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. Journal of Biological Chemistry 2002 277 19276-19280. (doi:10.1074/jbc.M202139200)
8. Abreu AP, Trarbach EB, de Castro M, Frade Costa EM, Versiani B, Matias Baptista MT, Garmes HM, Mendonca BB & Latronico AC. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 4113-4118. (doi:10.1210/jc.2008-0958)
9. Dodé C, Levilliers J,DupontJM,De Paepe A, LeDû N, Soussi-YanicostasN, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F et al. Lossof-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nature Genetics 2003 33 463-465. (doi:10.1038/ng1122)
10. Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genetics 2006 2 e175. (doi:10.1371/ journal.pgen.0020175)
11. Pitteloud N, Zhang C, Pignatelli D, Li JD, Raivio T, Cole LW, Plummer L, Jacobson-Dickman EE, Mellon PL, Zhou QY et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. PNAS 2007 104 17447-17452. (doi:10.1073/pnas.0707173104)
12. Trarbach EB, Costa EM,Versiani B, de CastroM,BaptistaMT,GarmesHM, de Mendonca BB&Latronico AC. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. Journal of Clinical Endocrinology and Metabolism 2006 91 4006-4012. (doi:10.1210/jc.2005-2793)
13. Asakura Y, Muroya K, Hanakawa J, Sato T, Aida N, Narumi S, Hasegawa T & AdachiM. Combined pituitary hormone deficiency with unique pituitary dysplasia and morning glory syndrome related to a heterozygous PROKR2 mutation. Clinical Pediatric Endocrinology 2015 24 27-32. (doi:10.1297/cpe.24.27)
14. Tanner JM, Whitehouse RH & Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965, II. Archives of Disease in Childhood 1966 41 613-635. (doi:10.1136/adc.41.220.613)
15. Raivio T, Sidis Y, Plummer L, Chen H, Ma J, Mukherjee A, Jacobson-Dickman E, Quinton R, Van Vliet G, Lavoie H et al. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2009 94 4380-4390. (doi:10.1210/jc.2009-0179)
16. Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophinreleasing hormone deficiency: molecular genetics and clinical spectrum. Journal of Clinical Endocrinology and Metabolism 2008 93 3551-3559. (doi:10.1210/jc.2007-2654)
17. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. PNAS 2010 107 15140-15144. (doi:10.1073/pnas.1009622107)
18. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431. (doi:10.1016/S0140-6736(00)04006-X)
19. Izumi Y, Suzuki E, Kanzaki S, Yatsuga S, Kinjo S, Igarashi M, Maruyama T, Sano S, Horikawa R, Sato N et al. Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism. Fertility and Sterility 2014 102 1130-1136.e3. (doi:10.1016/j.fertnstert.2014.06.017)
20. Mehta A, Hindmarsh PC, Mehta H, Turton JP, Russell-Eggitt I, Taylor D, Chong WK & Dattani MT. Congenital hypopituitarism: clinical, molecular and neuroradiological correlates. Clinical Endocrinology 2009 71 376-382. (doi:10.1111/j.1365-2265.2009.03572.x)
21. Osorio MG,Marui S, Jorge AA, Latronico AC, Lo LS, Leite CC, Estefan V, Mendonca BB & Arnhold IJ. Pituitarymagnetic resonance imaging and function in patients with growth hormone deficiency with and without mutationsinGHRH-R,GH-1,orPROP-1 genes. Journal ofClinical Endocrinology and Metabolism 2002 87 5076-5084. (doi:10.1210/jc.2001-011936)
22. Vermeulen S, Messiaen L, Scheir P, De Bie S, Speleman F & De Paepe A. Kallmann syndrome in a patient with congenital spherocytosis and an interstitial 8p11.2 deletion. American Journal of Medical Genetics 2002 108 315-318. (doi:10.1002/ajmg.10295)
23. Fukami M, Iso M, Sato N, Igarashi M, Seo M, Kazukawa I, Kinoshita E, Dateki S & Ogata T. Submicroscopic deletion involving the fibroblast growth factor receptor 1 gene in a patient with combined pituitary hormone deficiency. Endocrine Journal 2013 60 1013-1020. (doi:10.1507/endocrj.EJ13-0023)
24. Reynaud R, Jayakody SA, Monnier C, Saveanu A, Bouligand J, Guedj AM, Simonin G, Lecomte P, Barlier A, Rondard P et al. PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption. Journal of Clinical Endocrinology and Metabolism 2012 97 E1068-E1073. (doi:10.1210/jc.2011-3056)
25. McCabe MJ, Gaston-Massuet C, Gregory LC, Alatzoglou KS, Tziaferi V, Sbai O, Rondard P, Masumoto KH, Nagano M, Shigeyoshi Y et al. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia. Journal of Clinical Endocrinology and Metabolism 2013 98 E547-E557. (doi:10.1210/jc.2012-3067)
26. Abreu AP, Noel SD, Xu S, Carroll RS, Latronico AC & Kaiser UB. Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function. Molecular Endocrinology 2012 26 1417-1427. (doi:10.1210/me.2012-1102)
27. Monnier C, Dode C, Fabre L, Teixeira L, Labesse G, Pin JP, Hardelin JP & Rondard P. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity. Human Molecular Genetics 2009 18 75-81. (doi:10.1093/hmg/ddn318)